Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.54 USD | -0.52% | +13.40% | -14.54% |
26/04 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
22/03 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Sales 2024 * | 10M 834M | Sales 2025 * | 6.25M 521M | Capitalization | 1.16B 96.64B |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.83B | Net income 2025 * | -25M -2.09B | EV / Sales 2024 * | 110 x |
Net cash position 2024 * | 63.14M 5.27B | Net cash position 2025 * | 40.52M 3.38B | EV / Sales 2025 * | 179 x |
P/E ratio 2024 * |
-51.9
x | P/E ratio 2025 * |
-48.3
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.31% |
Latest transcript on Belite Bio, Inc
1 day | -0.52% | ||
1 week | +13.40% | ||
Current month | +1.90% | ||
1 month | +5.93% | ||
3 months | -14.12% | ||
6 months | +2.38% | ||
Current year | -14.54% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27/18/27 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01/20/01 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 01/22/01 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 01/22/01 |
John Longo
BRD | Director/Board Member | 55 | 01/22/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 39.1 | -1.64% | 4 974 |
26/24/26 | 39.75 | +4.61% | 46,599 |
25/24/25 | 38 | +1.96% | 16,035 |
24/24/24 | 37.27 | +0.73% | 32,733 |
23/24/23 | 37 | +7.31% | 38,820 |
Delayed Quote Nasdaq, April 29, 2024 at 09:53 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.54% | 1.16B | |
+2.64% | 42.75B | |
+47.70% | 41.61B | |
+12.06% | 41.34B | |
-8.83% | 26.59B | |
+7.43% | 25.49B | |
-22.63% | 18.12B | |
+30.61% | 12.24B | |
-1.81% | 11.76B | |
+9.10% | 11B |
- Stock Market
- Equities
- BLTE Stock